A scientist at Cincinnati Children’s who has hunted for decades for ways to shrink the painful and disfiguring nerve tumors caused by neurofibromatosis type 1 (NF1) has made a new breakthrough in the quest.
New drug class shows major promise for shrinking nerve tumors
- Post author:admin
- Post published:September 2, 2026
- Post category:uncategorized
- Post comments:0 Comments